234 related articles for article (PubMed ID: 36257181)
1. Malignant peripheral nerve sheath tumor of the maxilla: Case report and review of the literature with emphasis on its poor prognosis.
Oh KY; Hong SD
Oral Oncol; 2022 Dec; 135():106211. PubMed ID: 36257181
[TBL] [Abstract][Full Text] [Related]
2. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
3. Experience of a single center in the treatment of rare malignant peripheral nerve sheath tumors during the years 1991-2021.
Ptchelintseva A; Nuutinen H; Salo J; Tukiainen E
J Plast Surg Hand Surg; 2023; 57(1-6):376-382. PubMed ID: 36244030
[TBL] [Abstract][Full Text] [Related]
4. Gastric Malignant Peripheral Nerve Sheath Tumor in Type 1 Neurofibromatosis.
Hwang HS; Jeong YJ; Nam KH; Oh SJ; Park YE
Korean J Gastroenterol; 2022 Jun; 79(6):265-269. PubMed ID: 35746841
[TBL] [Abstract][Full Text] [Related]
5. Malignant Peripheral Nerve Sheath Tumors of the Brachial Plexus: A Single-Center Experience on Diagnosis, Management, and Outcomes.
Donaldson EK; Winter JM; Chandler RM; Clark TA; Giuffre JL
Ann Plast Surg; 2023 Apr; 90(4):339-342. PubMed ID: 36752552
[TBL] [Abstract][Full Text] [Related]
6. RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST.
Chung MH; Aimaier R; Yu Q; Li H; Li Y; Wei C; Gu Y; Wang W; Guo Z; Long M; Li Q; Wang Z
Cell Oncol (Dordr); 2023 Oct; 46(5):1399-1413. PubMed ID: 37086345
[TBL] [Abstract][Full Text] [Related]
7. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of malignant peripheral nerve sheath tumor: Experience of a tertiary center in Taiwan.
Chang YW; Liao WC
J Chin Med Assoc; 2023 Jun; 86(6):584-588. PubMed ID: 37071773
[TBL] [Abstract][Full Text] [Related]
9. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study.
Martin E; Coert JH; Flucke UE; Slooff WM; van de Sande MAJ; van Noesel MM; Grünhagen DJ; Wijnen MHWA; Verhoef C
Pediatr Blood Cancer; 2020 Apr; 67(4):e28138. PubMed ID: 31889416
[TBL] [Abstract][Full Text] [Related]
11. Malignant Peripheral Nerve Sheath Tumor Arising from Small Bowel Mesentery: an Extremely Rare Case with Review of Literature.
Zaheer S; Khosla D; Gupta V; Nada R; Kumar D; Kapoor R
J Gastrointest Cancer; 2023 Mar; 54(1):259-263. PubMed ID: 34796455
[TBL] [Abstract][Full Text] [Related]
12. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
[TBL] [Abstract][Full Text] [Related]
13. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
[TBL] [Abstract][Full Text] [Related]
14. Malignant peripheral nerve sheath tumor: models, biology, and translation.
Somatilaka BN; Sadek A; McKay RM; Le LQ
Oncogene; 2022 Apr; 41(17):2405-2421. PubMed ID: 35393544
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review.
Chowdhury A; Vivanco-Suarez J; Teferi N; Belzer A; Al-Kaylani H; Challa M; Lee S; Buatti JM; Hitchon P
World J Surg Oncol; 2023 Oct; 21(1):338. PubMed ID: 37880773
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.
Lim Z; Gu TY; Tai BC; Puhaindran ME
World J Surg Oncol; 2024 Jan; 22(1):14. PubMed ID: 38191386
[TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
[TBL] [Abstract][Full Text] [Related]
18. Sporadic malignant peripheral nerve sheath tumour (MPNST) in a 3-year-old girl: A diagnostic challenge.
Zawawi MSF; Wan Ismail WFN; Mustapar N; Mohamad N; Nasir A; Tuan Sharif SE
Malays J Pathol; 2022 Apr; 44(1):115-120. PubMed ID: 35484894
[TBL] [Abstract][Full Text] [Related]
19. Giant malignant peripheral nerve sheath tumor of the scalp.
F T; A M M A; B A de L; T C C C; R C L; G H T S B; H C
Acta Neurol Taiwan; 2012 Sep; 21(3):133-5. PubMed ID: 23196734
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R
Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
